Tianfu International Biocity: Build Global Bioindustry-city

Chengdu Tianfu Global International Biocity

PR98288

 

CHENGDU, China, Oct. 14, 2022 /Xinhua=KYODO JBN/--

 

On Oct.10, Chengdu Tianfu Global International Biocity saw the signing of ten

project agreements totalling nearly 9B CNY in value and covering modern

biopharmaceuticals, innovative chemical drugs, sophisticated medical

apparatuses and other important fields.

 

Geneseeq, a Chinese genetic disease testing giant, intends to invest in a local

facility and industrialization base of genetic infection and tumor diagnosis as

southwestern China-based its headquarters. They're devoted to becoming

Geneseeq's second head office in China as well as the pacesetter of testing &

diagnosis in midwestern China.

 

Shanghai Siyi Intelligent Technology Co., Ltd., a leading Chinese soft robotics

manufacturer, will build a rehabilitation platform that integrates the

hospital, community and family. At the same time, Siyi will locate its

operating head office, listed company office and manufacturing facility to

Tianfu International Biocity.

 

"Tianfu International Biocity helps us with both investment and subsidy to

support the projects and solve investment and financing problems. From the

perspective of upstream and downstream analysis, improve the industry chain and

save us a lot time in upstream-downstream communication," said Yin Ganggang,

founder of Siyi.    

 

"The signing of these agreements will make bioindustrial innovation

transformation. In the future, the biocity will continue to build more project

clusters that consistently gain in magnitude and promote the industry of

pharmaceuticals," said the spokesman of Chengdu Tianfu International Biocity.  

 

Commenced in March 2016 and located in southwestern Shuangliu (part of Chengdu,

the capital of Sichuan), Chengdu Tianfu International Biocity has a planned

area of around 44 square kilometers. The Biocity includes five industries, i.e.

biopharmaceuticals, innovative chemical drugs, high-performance medical

equipment, professional outsourcing service and health service. These

industries are intended to promote the close combination of the industry chain,

innovation chain and supply chain, therefore adding to the local driving force

and competitiveness of the modern industry.

 

Since foundation, Tianfu International Biocity has seen its bioindustry gain in

economic contribution and competitiveness. The first-phase 9-km city framework

is already in place.

 

In order to attract investments from biopharmaceutical professionals, Chengdu

Tianfu International Ecocity attaches importance to urban livability, constant

improvements in urban functions, worker-inhabitant balance improvement and life

convenience in order to meet the residential requirements of local people and

company employees. Yong'an Lake Urban Forest Park, Incubator Shopping Street,

community complexes and other business models are contributing step by step to

such consumer markets as food, hospitality, travel, tourism, shopping and

recreation. Now, Chengdu Tianfu International Biocity is on its way to becoming

a global base of innovative biopharmaceuticals.

 

Source: Chengdu Tianfu Global International Biocity

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中